This week, Burlington-headquartered life-sciences company LabCorp announced it received an Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 at-home test kit.
The kits will be offered through the Pixel by LabCorp™ platform and initially be made available to healthcare workers and first responders.
LabCorp intends to make COVID-19 self-collection kits available to consumers in the coming weeks. Future updates about the self-collection kits can be found on LabCorp’s COVID-19 microsite.
"LabCorp continues to develop new ways to help patients and healthcare providers fight the COVID-19 crisis through our leading testing capabilities and deep scientific and research expertise,” said Adam Schechter, president and CEO of LabCorp. “Our at-home collection kits are designed to make it easier and safer to test healthcare workers and first responders during this important time.”
LabCorp's leadership in the response to COVID-19 and their commitment to providing fast, accurate solutions to the healthcare community are critical in this pandemic. Alamance County is thankful to be home to LabCorp and the many dedicated scientists, technicians and their support staffs who are delivering for the world!